SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BONDANELLI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.886
AS - Asia 6.915
EU - Europa 4.658
SA - Sud America 1.092
AF - Africa 154
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 23.722
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.584
SG - Singapore 2.689
CN - Cina 1.790
DE - Germania 1.454
BR - Brasile 868
VN - Vietnam 730
IT - Italia 717
UA - Ucraina 693
HK - Hong Kong 588
GB - Regno Unito 370
RU - Federazione Russa 342
TR - Turchia 335
FI - Finlandia 289
FR - Francia 261
JP - Giappone 179
PL - Polonia 159
IN - India 146
SE - Svezia 141
MX - Messico 132
CA - Canada 124
AR - Argentina 78
BD - Bangladesh 78
ID - Indonesia 74
IQ - Iraq 57
ZA - Sudafrica 56
NL - Olanda 53
PK - Pakistan 48
EC - Ecuador 43
ES - Italia 38
VE - Venezuela 30
BE - Belgio 24
CO - Colombia 23
SA - Arabia Saudita 22
MY - Malesia 21
LT - Lituania 20
UZ - Uzbekistan 20
MA - Marocco 19
TN - Tunisia 19
AE - Emirati Arabi Uniti 17
PH - Filippine 17
AT - Austria 16
CL - Cile 16
AU - Australia 12
IE - Irlanda 11
JO - Giordania 11
AL - Albania 10
BO - Bolivia 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
DK - Danimarca 8
EG - Egitto 8
JM - Giamaica 8
KE - Kenya 8
LB - Libano 8
PA - Panama 8
PS - Palestinian Territory 8
TH - Thailandia 8
AZ - Azerbaigian 7
ET - Etiopia 7
IL - Israele 7
KR - Corea 7
KZ - Kazakistan 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
PE - Perù 6
RO - Romania 6
CH - Svizzera 5
KG - Kirghizistan 5
NP - Nepal 5
TT - Trinidad e Tobago 5
CY - Cipro 4
GA - Gabon 4
IR - Iran 4
LV - Lettonia 4
NG - Nigeria 4
NI - Nicaragua 4
AO - Angola 3
BF - Burkina Faso 3
BG - Bulgaria 3
BH - Bahrain 3
CR - Costa Rica 3
GR - Grecia 3
HU - Ungheria 3
PT - Portogallo 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
EU - Europa 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MD - Moldavia 2
MM - Myanmar 2
Totale 23.688
Salva come PNG Salva come JPEG
Città #
Singapore 1.720
Ashburn 1.233
Woodbridge 905
San Jose 834
Chandler 722
Jacksonville 678
Fairfield 604
Hong Kong 577
Beijing 575
Santa Clara 564
Houston 413
Ann Arbor 342
Wilmington 278
Ho Chi Minh City 242
Seattle 220
New York 212
Izmir 207
Nanjing 203
Addison 202
Los Angeles 196
Cambridge 183
Munich 176
Hanoi 172
Tokyo 171
Dallas 161
Princeton 155
Warsaw 152
Lauterbourg 139
Milan 124
Helsinki 111
San Diego 96
São Paulo 90
Shanghai 88
Mexico City 79
Council Bluffs 70
Shenyang 70
Boardman 66
Ferrara 64
Hebei 56
Hefei 55
Orem 55
Dearborn 50
London 50
Turku 47
Nanchang 46
Montreal 45
Tianjin 45
Buffalo 41
Chennai 40
Bremen 39
Chicago 39
Changsha 38
Haiphong 38
Jakarta 37
Brooklyn 33
Toronto 33
Denver 32
Phoenix 31
Jiaxing 30
Johannesburg 30
Moscow 30
Rome 30
Manchester 29
Poplar 29
San Francisco 29
Stockholm 29
Da Nang 28
Kunming 27
Washington 26
Bologna 25
Falls Church 25
Frankfurt am Main 25
Baghdad 24
Jinan 24
Redwood City 24
Rio de Janeiro 24
Atlanta 23
Brussels 23
Mountain View 23
Boston 22
Mumbai 22
Hải Dương 21
Norwalk 21
Quito 21
Amsterdam 20
Lahore 20
Belo Horizonte 19
Guangzhou 18
Zhengzhou 18
Curitiba 17
Tashkent 17
Ankara 16
Falkenstein 16
Brasília 15
Campinas 15
Ningbo 15
Dhaka 14
San Mateo 14
Biên Hòa 13
City of London 13
Totale 14.868
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 312
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 260
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 248
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 232
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 232
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 230
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 229
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 223
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 213
Acromegaly is associated with increased cancer risk: a survey in Italy 212
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 210
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 207
Growth hormone excess promotes breast cancer chemoresistance 205
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 201
Antiproliferative effects of somatostatin analogs in pituitary adenomas 200
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 198
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 197
Diurnal rhythm of plasma catecholamines in acromegaly 196
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 196
A new VHL polymorphism in a big family from Ferrara 191
L’iperplasia surrenale congenita e la pubertà precoce 186
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 186
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 185
Pituitary side effects of old and new drugs. 184
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 181
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 181
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 180
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 179
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 178
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 178
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 177
In vitro testing of new somatostatin analogs on pituitary tumor cells 176
Glucose metabolism alterations in acromegaly 176
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 176
Cerebral aneurysm and acromegaly: a case report 175
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 175
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 174
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 172
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 172
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 171
ASSE GH-IGF-I NELL'INVECCHIAMENTO 170
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 170
Role of the serotonergic system in the genesis of vasovagal syncope 169
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 169
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 168
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 167
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 167
Functional hypothalamic and drug-induced amenorrhea: an overview 167
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study 166
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 166
Le alterazioni pressorie nell'acromegalia: fattori umorali 166
Delta opioid receptor involvement in endocrine pathophysiology 163
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 162
Sistema Simpatoadrenomidollare nei pazienti acromegalici 161
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 160
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 158
Cerebrovascular disease and GH-IGF-i axis function 157
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 157
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 156
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 156
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 156
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 156
Replacement therapy and quality of life improvement in adult GHD patients 156
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 155
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 153
Bone metastases frequency, distribution, clinical and imaging characteristics in neuroendocrine tumors: our experience 152
Acromegaly in the elderly patients 152
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 148
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 148
Effects of pasireotide on bronchial carcinoids in primary culture 148
Efficay and safety of teriparatide treatment 148
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 148
Prevalence of hypopituitarismin patients with cerebrovascular diseases 146
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 146
Role of GH-IGF-1 excess on periodontal tissues 145
Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy 144
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation. 144
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study 143
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 142
Human galanin reduces plasma norepinephrine levels in man 142
Clinica e diagnostica dei tumori neuroendocrini 142
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 142
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 140
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 139
Predictors of morbidity and mortality in acromegaly: An Italian survey 139
Systemic illness 138
RELIABILITY OF QUANTITATIVE ULTRASOUND IN THE FOLLOW-UP OF ADULTS WITH GH DEFICIENCY UNDERGOING REPLACEMENT THERAPY 137
INVECCHIAMENTO E GH 137
Successful treatment with everolimus of functioning liver metastases from a pancreatic insulinoma 137
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 137
Craniopharyngioma and Eating Disorders 136
Occurrence of pituitary dysfunction following traumatic brain injury 134
La terapia dei tumori neuroendocrini. 134
Tumori neuroendocrini: i meccanismi fisiopatologici 134
Differential effects of deltorphin on arginine and galanin-induced growth hormone secretion in healthy man. 134
FISIOPATOLOGIA, CLASSIFICAZIONE, PATOGENESI (ACROMEGALIA) 132
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation 130
Pathogenesis and prevalence of hypertension in acromegaly 130
null 130
Evaluation of NEP-SCORE Applicability in a Series of Patients with IV Stage NEN 129
Totale 16.912
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 13.700
Totale 116.628
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021450 0 0 0 0 0 0 0 0 0 185 198 67
2021/20221.387 36 139 90 60 55 58 48 61 42 120 118 560
2022/20231.527 155 136 52 203 207 230 74 114 214 16 69 57
2023/2024834 68 95 50 25 51 176 25 79 25 24 24 192
2024/20253.452 99 76 267 106 419 359 129 131 579 428 483 376
2025/20269.219 939 384 800 1.162 1.615 631 1.178 535 892 1.083 0 0
Totale 23.918